A panel of advisers to the Food and Drug Administration meets Thursday to evaluate Pfizer’s COVID-19 vaccine and make recommendations on emergency use to the agency.
Jacquelyn Martin/AP
hide caption
toggle caption
Jacquelyn Martin/AP
A panel of advisers to the Food and Drug Administration meets Thursday to evaluate Pfizer’s COVID-19 vaccine and make recommendations on emergency use to the agency.
Jacquelyn Martin/AP
hide caption
toggle caption
Jacquelyn Martin/AP